Yin, Henry; Bardgett, Mark E; Csernansky, John G (2002) Kainic acid lesions disrupt fear-mediated memory processing. Neurobiol Learn Mem 77:389-401
|
Bardgett, Mark E; Humphrey, William M; Csernansky, John G (2002) The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppression. Neuropsychopharmacology 27:930-8
|
Drevets, Wayne C; Price, Joseph L; Bardgett, Mark E et al. (2002) Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol Biochem Behav 71:431-47
|
Humphrey, W M; Bardgett, M E; Montgomery, E M et al. (2001) Methods for inducing neuronal loss in preweanling rats using intracerebroventricular infusion of kainic acid. Brain Res Brain Res Protoc 7:1-10
|
Jacobs, P S; Taylor, B M; Bardgett, M E (2000) Maturation of locomotor and Fos responses to the NMDA antagonists, PCP and MK-801. Brain Res Dev Brain Res 122:91-5
|
Bardgett, M E; Henry, J D (1999) Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors. Neuroscience 94:59-70
|
Montgomery, E M; Bardgett, M E; Lall, B et al. (1999) Delayed neuronal loss after administration of intracerebroventricular kainic acid to preweanling rats. Brain Res Dev Brain Res 112:107-16
|
Brenner, D M; Bardgett, M E (1998) Haloperidol blocks increased locomotor activity elicited by carbachol infusion into the ventral hippocampal formation. Pharmacol Biochem Behav 60:759-64
|
Csernansky, J G; Csernansky, C A; Kogelman, L et al. (1998) Progressive neurodegeneration after intracerebroventricular kainic acid administration in rats: implications for schizophrenia? Biol Psychiatry 44:1143-50
|
Newcomer, J W; Craft, S; Askins, K et al. (1998) Glucocorticoid interactions with memory function in schizophrenia. Psychoneuroendocrinology 23:65-72
|
Showing the most recent 10 out of 16 publications